Lactéol
Commercial- Indications
- Digestive health, Gut upsets
Company intelligence / Profile preview
Adare Biome has commercialized its lead pharmaceutical product Lactéol™, which has broad international distribution. Its postbiotic ingredients LBiome™ and LBiotix™ are used in human, pet, and production animal digestive health applications. The company’s acquisition by dsm-firmenich aims to expand its reach into new markets including dietary supplements and early life/medical nutrition. No clinical trial data was identified.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adare Biome.